FHTX

1.7203.37%
BL

B. Lynne Parshall

Independent Director

Ms. B. Lynne Parshall, Esq., J.D., is Director of Repertoire Immune Medicines, Inc. from December 2021. Ms. Parshall serves as Director at Alltrna, Inc. from July, 2024. She is Chief Executive Officer of Lyme Pinnacle Consulting and had been a Director at Ionis Pharmaceuticals, Inc. since September 2000 to 2026. She serves as an Independent Director of Foghorn Therapeutics Inc. from August 2022. She is Director of Ring Therapeutics, Inc. from March 2022. She had been Chairman of the Board at Akcea Therapeutics, Inc. since December 16, 2019 until October 12, 2020. Ms. Parshall serves as a Director at Repertoire Immune Medicines, Inc., since December 2021. She had been Senior Strategic Advisor of Ionis Pharmaceuticals, Inc. (also known as Isis Pharmaceuticals, Inc.) since January 15, 2018 until December 2022 and served as its Chief Operating Officer from December 2007 to January 15, 2018 and served as its Chief Financial Officer and served as its Corporate Secretary until 2014. Ms. Parshall served as Secretary at Isis Pharmaceuticals, Inc. since November 1991. Ms. Parshall served as an Executive Vice President since December 1995, Chief Financial Officer from June 1994 to December 2012, Senior Vice President from February 1993 to December 1995 and Vice President from November 1991 to February 1993 of Isis Pharmaceuticals, Inc. and also served as its Principal Accounting Officer. Ms. Parshall joined Isis in November 1991. Previously, she was a Partner with Cooley Godward LLP from 1986 to 1991, where she represented several health care companies in a general practice specializing in corporate Partnering and other technology-based transactions. Ms. Parshall has experience structuring and negotiating strategic licensing and financing transactions in the life sciences field, finance and operations in the biotechnology industry. She is on the Board of Celdara Medical since 2023. Prior to working in industry, she was a partner at the Cooley law firm with a practice focusing on securities law and biotechnology corporate partnering. Ms. Parshall serves as an Independent Director Cytokinetics, Incorporated since February 7, 2013. Ms. Parshall served as Director of Akcea Therapeutics, Inc. from January 2015 to October 12, 2020. She served as a Director at Regulus Therapeutics Inc., from January 2009 to June 10, 2015. Ms. Parshall served as a Director of Regulus Therapeutics LLC since November 2007. She served as a Director of Corautus Genetics Inc. since May 2005 and VIA Pharmaceuticals, Inc. until June 5, 2007. From July 2005 to August 2009, Ms. Parshall also served as a Member of the Board of Directors of Cardiodynamics International Corporation, a publicly-held biopharmaceutical company. She served as a Board Member at ProtoGene Laboratories, Inc. She serves on the Board of Visitors at Stanford University Law School. Ms. Parshall serves on the Surf Soccer Board of Directors. She is a Trustee of The Bishop School in La Jolla. She is a Member of the Licensing Executives Society and of the American, California and San Diego bar associations. Ms. Parshall received her NACD Directorship Certification in 2023 and her NACD Cybersecurity Expert Certification in 2024. Ms. Parshall started her career and practiced law at Cooley Godward Kronish LLP and remains a Member of the American and California Bar Associations. Ms. Parshall received her J.D. at Stanford Law School, Stanford, California and her A.B. from Harvard University, Cambridge, Massachusetts and BS from Harvard University.

Positions